CAC
Core Alternative Capital’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Hold |
319
| – | – | 0.01% | 144 |
|
|
2025
Q1 | $32.2K | Sell |
319
-51
| -14% | -$5.15K | 0.01% | 151 |
|
|
2024
Q4 | $33K | Hold |
370
| – | – | 0.01% | 167 |
|
|
2024
Q3 | $31K | Hold |
370
| – | – | 0.01% | 170 |
|
|
2024
Q2 | $28.5K | Hold |
370
| – | – | 0.01% | 173 |
|
|
2024
Q1 | $25.3K | Sell |
370
-611
| -62% | -$41.8K | ﹤0.01% | 175 |
|
|
2023
Q4 | $56.7K | Sell |
981
-1,193
| -55% | -$69K | 0.01% | 159 |
|
|
2023
Q3 | $115K | Buy |
2,174
+450
| +26% | +$23.8K | 0.02% | 136 |
|
|
2023
Q2 | $93.3K | Sell |
1,724
-66
| -4% | -$3.57K | 0.01% | 125 |
|
|
2023
Q1 | $89.6K | Buy |
1,790
+414
| +30% | +$20.7K | 0.01% | 120 |
|
|
2022
Q4 | $63.7K | Sell |
1,376
-68
| -5% | -$3.15K | 0.01% | 139 |
|
|
2022
Q3 | $56K | Buy |
1,444
+136
| +10% | +$5.27K | 0.01% | 137 |
|
|
2022
Q2 | $49K | Buy |
1,308
+102
| +8% | +$3.82K | 0.01% | 150 |
|
|
2022
Q1 | $53K | Buy |
1,206
+1,018
| +541% | +$44.7K | 0.01% | 143 |
|
|
2021
Q4 | $8K | Buy |
+188
| New | +$8K | ﹤0.01% | 147 |
|